Lex Aurum Advisors, LLC Merck & Co., Inc. Transaction History

Lex Aurum Advisors, LLC

$430 Million
Q3 2024

A detailed history of Lex Aurum Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lex Aurum Advisors, LLC holds 11,050 shares of MRK stock, worth $1.08 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

11,050

Previous 10,988 0.56%

Holding current value

$1.08 Million

Previous $1.36 Million 7.79%

% of portfolio

0.29%

Previous 0.34%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$111.15 - $128.97 $6,891 - $7,996	62 Added 0.56%	11,050 $1.25 Million
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $56,205 - $60,363	-454 Reduced 3.97%	10,988 $1.36 Million
Q1 2024 Apr 10, 2024	BUY	$113.24 - $131.95 $4,642 - $5,409	41 Added 0.36%	11,442 $1.51 Million
Q4 2023 Jan 10, 2024	SELL	$100.18 - $109.02 $1,402 - $1,526	-14 Reduced 0.12%	11,401 $1.24 Million
Q3 2023 Oct 16, 2023	BUY	$102.95 - $114.33 $62,181 - $69,055	604 Added 5.59%	11,415 $1.18 Million
Q2 2023 Jul 25, 2023	BUY	$108.61 - $118.38 $61,581 - $67,121	567 Added 5.53%	10,811 $1.25 Million
Q1 2023 Apr 11, 2023	SELL	$102.94 - $114.86 $5,867 - $6,547	-57 Reduced 0.55%	10,244 $1.09 Million
Q4 2022 Jan 23, 2023	SELL	$87.44 - $112.11 $8,831 - $11,323	-101 Reduced 0.97%	10,301 $0
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $169 - $189	-2 Reduced 0.02%	10,402 $896,000
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $2,254 - $2,555	27 Added 0.26%	10,404 $949,000
Q1 2022 May 04, 2022	SELL	$73.51 - $82.4 $113,499 - $127,225	-1,544 Reduced 12.95%	10,377 $851,000
Q4 2021 Jan 24, 2022	BUY	$72.28 - $90.54 $81,531 - $102,129	1,128 Added 10.45%	11,921 $914,000
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $5,591 - $6,148	78 Added 0.73%	10,793 $811,000
Q2 2021 Jul 19, 2021	BUY	$70.31 - $77.77 $52,873 - $58,483	752 Added 7.55%	10,715 $833,000
Q1 2021 Apr 22, 2021	SELL	$68.86 - $81.11 $1,032 - $1,216	-15 Reduced 0.15%	9,963 $768,000
Q4 2020 Jan 20, 2021	SELL	$71.77 - $79.65 $7,248 - $8,044	-101 Reduced 1.0%	9,978 $816,000
Q3 2020 Oct 22, 2020	BUY	$73.18 - $82.95 $20,856 - $23,640	285 Added 2.91%	10,079 $836,000
Q2 2020 Jul 22, 2020	SELL	$70.42 - $80.13 $211 - $240	-3 Reduced 0.03%	9,794 $757,000
Q1 2020 Apr 22, 2020	BUY	$63.36 - $87.82 $170,058 - $235,708	2,684 Added 37.73%	9,797 $754,000
Q4 2019 Jan 27, 2020	BUY	$77.58 - $87.54 $12,412 - $14,006	160 Added 2.3%	7,113 $647,000
Q3 2019 Oct 17, 2019	BUY	$76.08 - $82.93 $22,063 - $24,049	290 Added 4.35%	6,953 $585,000
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $12,134 - $14,082	186 Added 2.87%	6,663 $509,000
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $17,307 - $20,352	-300 Reduced 4.43%	6,477 $459,000
Q2 2018 Aug 07, 2018	BUY	$50.83 - $59.72 $12,707 - $14,930	250 Added 3.83%	6,777 $411,000
Q1 2018 May 09, 2018	SELL	$50.96 - $59.23 $15,237 - $17,709	-299 Reduced 4.38%	6,527 $356,000
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $352,358 - $420,754	6,826	6,826 $400,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lex Aurum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lex Aurum Advisors, LLC with notifications on news.

Account

Lex Aurum Advisors, LLC Merck & Co., Inc. Transaction History